Package Leaflet: Information for the User
GABAPENTIN TECNIGEN 600 MG FILM-COATED TABLETS EFG
Gabapentin
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack:
Gabapentina TecniGen belongs to a group of medicines used to treat epilepsy and peripheral neuropathic pain (long-lasting pain caused by damage to the nerves).
The active substance of Gabapentina TecniGen is gabapentin.
Gabapentina TecniGen is used to treat:
Peripheral neuropathic pain (long-lasting pain caused by damage to the nerves): A wide variety of diseases can cause peripheral neuropathic pain (mainly in the legs and/or arms), such as diabetes or herpes. The sensations of pain can be described as heat, burning, pulsating pain, flashing pain, stabbing pain, acute pain, spasms, continuous pain, tingling, numbness, and sensation of pinching, etc.
Do not take Gabapentina TecniGen:
If you are allergic to gabapentin or any of the other components of this medicine (listed in section 6).
Warnings and precautions:
Consult your doctor, pharmacist, or nurse before starting to take Gabapentina TecniGen.
In post-marketing experience, cases of abuse and dependence have been reported with gabapentin. Talk to your doctor if you have a history of abuse or dependence.
Dependence
Some people may develop dependence (need to continue taking the medicine) on Gabapentina TecniGen. They may experience withdrawal syndrome when they stop taking Gabapentina TecniGen (see section 3, "How to take Gabapentina TecniGen" and "If you stop taking Gabapentina TecniGen"). If you are concerned about developing dependence on Gabapentina TecniGen, it is essential that you consult your doctor.
If you experience any of the following signs while taking Gabapentina TecniGen, it may be indicative of dependence.
If you notice any of the above, talk to your doctor to decide what is the best course of treatment for you, including when it is appropriate to stop treatment and how to do it safely.
Severe skin reactions have been reported with the use of gabapentin, including Stevens-Johnson syndrome, toxic epidermal necrolysis, and drug rash with eosinophilia and systemic symptoms (DRESS). Stop taking gabapentin and seek medical attention immediately if you notice any of the symptoms related to these severe skin reactions described in section 4.
Important information about potentially serious reactions
A small number of people taking Gabapentina TecniGen have allergic reactions or potentially serious skin reactions, which can lead to more serious problems if not treated. It is necessary that you know the symptoms of these reactions and be aware of them while taking Gabapentina TecniGen.
Read the description of these symptoms in section 4 of this leafletin "Contact your doctor immediately if you experience any of the following symptoms after taking this medicine, as they may be serious".
Muscle weakness, sensitivity, or pain, and especially if you do not feel well or have a high fever, which can be caused by abnormal muscle breakdown, which can be life-threatening and lead to kidney problems. You may also experience urine discoloration and changes in blood test results (especially increased creatine phosphokinase in the blood). If you experience any of these signs or symptoms, please contact your doctor immediately.
Use of other medicines:
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines. In particular, tell your doctor (or pharmacist) if you are taking or have recently taken any medicines for seizures, sleep disorders, depression, anxiety, or any other neurological or psychiatric problem.
Medicines containing opioids, such as morphine
If you are using medicines containing opioids (such as morphine), please tell your doctor or pharmacist, as opioids can increase the effect of Gabapentina TecniGen.
Additionally, the combination of Gabapentina TecniGen with opioids can cause symptoms such as drowsiness and/or decreased breathing.
Antacids for indigestion
If you take Gabapentina TecniGen at the same time as antacids containing aluminum and magnesium, the absorption of Gabapentina TecniGen in the stomach may be reduced. Therefore, it is recommended that Gabapentina TecniGen be taken at least two hours after taking an antacid.
Gabapentina TecniGen:
Taking Gabapentina TecniGen with food and drinks:
Gabapentina TecniGen can be taken with or without food.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
Gabapentina TecniGen should not be taken during pregnancy, unless your doctor has told you to do so. An effective contraceptive method should be used in women of childbearing age.
There are no specific studies with gabapentin in pregnant women, but other medicines used to treat seizures have caused an increased risk of harm to the developing fetus, particularly when used at the same time as more than one medicine to treat seizures. Therefore, whenever possible, you should try to take only one medicine for seizures during pregnancy and only under the advice of your doctor.
Contact your doctor immediately if you become pregnant, think you may be pregnant, or are planning to become pregnant while taking Gabapentina TecniGen. Do not stop taking this medicine suddenly, as this may cause seizures to occur, which could have serious consequences for you and your baby.
If taken during pregnancy, gabapentin may cause withdrawal symptoms in newborns. This risk may be higher when gabapentin is taken with opioid analgesics (drugs for treating intense pain).
Breastfeeding
Gabapentin, the active substance of Gabapentina TecniGen, passes into breast milk. Breastfeeding is not recommended while taking Gabapentina TecniGen, as the effect on the baby is unknown.
Fertility
There has been no effect on fertility in animal studies.
Driving and using machines:
Gabapentina may cause dizziness, drowsiness, and fatigue. You should not drive or use machines or perform potentially hazardous activities until you know if this medicine affects your ability to perform these activities.
Follow exactly the administration instructions of Gabapentina TecniGen indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again. Do not take a larger amount of medicine than prescribed.
Your doctor will determine what dose is appropriate for you.
Epilepsy, the recommended dose is:
Adults and adolescents:
Take the number of tablets indicated by your doctor. Normally, your doctor will gradually increase the dose. The initial dose will usually be 300 to 900 mg per day. From there, the dose may be increased as indicated by your doctor up to a maximum dose of 3600 mg per day, divided into three equal doses, for example, one in the morning, one at noon, and one at night.
Use in children 6 years of age or older:
The dose to be given to your child will be decided by your doctor based on the child's weight. The treatment starts with a low initial dose that will be gradually increased over a period of approximately 3 days. The recommended dose for controlling epilepsy is 25-35 mg per kg of body weight per day. The dose is normally administered by taking the tablets, divided into 3 equal doses per day, usually one in the morning, one at noon, and one at night.
Gabapentina TecniGen is not recommended for use in children under 6 years of age.
Peripheral neuropathic pain, the recommended dose is:
Adults:
Take the number of tablets indicated by your doctor. Normally, your doctor will gradually increase the dose. The initial dose will usually be 300 to 900 mg per day. From there, the dose may be increased as indicated by your doctor up to a maximum dose of 3600 mg per day, divided into three equal doses, for example, one in the morning, one at noon, and one at night.
If you have kidney problems or are on hemodialysis
Your doctor may prescribe a different dosing regimen and/or different doses if you have kidney problems or are on hemodialysis.
If you are an elderly patient (over 65 years of age),you should take the normal dose of Gabapentina TecniGen unless you have kidney problems. Your doctor may prescribe a different dose and/or a different dosing schedule if you have kidney problems.
If you think that the effect of Gabapentina TecniGen is too strong or too weak, consult your doctor or pharmacist as soon as possible.
Method of administration
Gabapentina TecniGen is for oral use. Always swallow the tablets whole with plenty of water.
Continue taking Gabapentina TecniGen until your doctor tells you to stop.
If you take more Gabapentina TecniGen than you should:
If you or someone else accidentally takes too many tablets, or if you think a child has swallowed some of the tablets, contact your doctor or go to the nearest hospital emergency department immediately. As Gabapentina TecniGen tablets can cause drowsiness, it is recommended that you ask someone to take you to your doctor or hospital, or call an ambulance.
Take any remaining tablets and the packaging with you to the hospital so that the medicine can be easily identified.
The symptoms of an overdose are dizziness, double vision, difficulty speaking, loss of consciousness, drowsiness, and mild diarrhea.
If you forget to take Gabapentina TecniGen:
If you forget to take a dose, take it as soon as you remember, unless it is almost time for your next dose. Do not take a double dose to make up for a forgotten dose.
If you stop taking Gabapentina TecniGen
Do not stop taking Gabapentina TecniGen suddenly. If you want to stop taking Gabapentina TecniGen, talk to your doctor first. Your doctor will tell you how to proceed. If you are going to stop treatment, it should be done gradually over a minimum of one week. You should be aware that you may experience certain side effects, called withdrawal syndrome, after stopping short-term or long-term treatment with Gabapentina TecniGen. These include seizures, anxiety, difficulty sleeping, feeling unwell (nausea), pain, sweating, tremors, headache, depression, abnormal sensation, dizziness, and general feeling of being unwell. These effects usually occur within the first 48 hours after stopping treatment with Gabapentina TecniGen. If you experience this withdrawal syndrome, you should contact your doctor.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.
Stop taking Gabapentina TecniGen and seek immediate medical attention if you notice any of these symptoms:
Like all medicines, Gabapentina TecniGen can cause adverse effects, although not all people will experience them.
Contact your doctor immediately if you experience any of the following symptoms after taking this medication, as they can be serious:
These symptoms can be the first signs of a severe reaction. A doctor should examine you to decide if you should continue taking Gabapentina TecniGen.
If you are on hemodialysis, inform your doctor if you start to feel muscle pain and/or weakness.
Other adverse effects include:
Very common (may affect more than 1 in 10 people):
Common (may affect up to 1 in 10 people):
Additionally, in clinical trials in children, aggressive behavior and spasmodic movements were reported as frequent adverse effects.
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Frequency not known(cannot be estimated from available data):
You should know that you may experience certain adverse effects, called withdrawal syndrome, after interrupting short-term or long-term treatment with Gabapentina TecniGen (see "If you stop taking Gabapentina TecniGen").
Since the introduction of the medication to the market, the following adverse effects have been reported:
Reporting adverse effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse,
even if it is a possible adverse effect that is not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: http://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep out of sight and reach of children.
Do not use this medication after the expiration date stated on the packaging after CAD. The expiration date is the last day of the month indicated.
Do not store above 25°C. Store in the original packaging to protect from light and moisture.
Medicines should not be disposed of through wastewater or household waste. Deposit the packaging and any unused medication in the pharmacy's SIGRE point. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.
Composition of Gabapentina TecniGen 600 mg tablets
Tablet core:
Povidone K-90,
crospovidone,
Poloxamer 407,
magnesium stearate.
Coating:
Opadry 20A28569 (Hydroxypropylcellulose, talc).
Appearance of the product and package contents
Gabapentina TecniGen is presented in the form of film-coated tablets. The tablets are white, convex, and elliptical in shape.
The tablets are packaged in PVC+PVdC/aluminum or OPA/aluminum blisters.
Gabapentina TecniGen 600 mg tablets are available in packages of 10, 50, 60, 90, or 100 tablets.
Not all package sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Tecnimede España Industria Farmacéutica, S.A.
Avda. de Bruselas, 13, 3º D. Edificio América. Polígono Arroyo de la Vega,
28108 Alcobendas (Madrid). ESPAÑA
Tel: 91 3835166
Fax: 91 3835167
E-mail: registros@tecnimede.es
Manufacturer
West Pharma - Producções de Especialidades Farmacêuticas, S.A.
Rua João de Deus, nº 11, Venda Nova. 2700 Amadora (Portugal).
Atlantic Pharma – Produções Farmacêuticas S.A.
Rua da Tapada Grande, n.º 2, Abrunheira, 2710-089 Sintra, Portugal
Farmalabor – Produtos Farmacêuticos, S.A.
Zona Industrial de Condeixa-a-Nova
3150-194 Condeixa-a-Nova
Portugal
This medication is authorized in the member states of the European Economic Area under the following names:
Spain: Gabapentina TecniGen
Poland: Gabatem
Portugal: Gabapentina Farmoz
United Kingdom: Gabapentin 600 mg
This leaflet was approved in March 2023
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of GABAPENTINA TECNIGEN 600 mg FILM-COATED TABLETS in October, 2025 is around 18.45 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.